Search

Search Constraints

You searched for: Author/Creator Billingham, L.

Search Results

3. 3434 A UK national phase I/II clinical trial of a MEK1/2 inhibitor combined with highly active anti-retroviral therapy for HIV-associated Kaposi's sarcoma. (September 2015)

5. OC-0086: A sarcoma hypoxia signature (nanoString® assay) validates in the phase III VorteX radiotherapy trial. (November 2020)